Week of April 8, 2024
The Wall Street Journal published an article on April 7, 2024 noting that the “…Needham Growth Fund (NEEGX), a $208 million midcap growth portfolio… ranked third…” for performance in the first quarter of 2024. The article then notes that one of the portfolio companies is Thermo Fisher Scientific, a $220 billion market capitalization company. Plainly, this company can hardly be considered a middle-sized company, so one has to wonder if this is an accurate “apples to apples” comparison in the category of mid cap mutual funds. Buyer beware. Our Signals remain unchanged this week.
Bob Bilkie, CFA